2020
DOI: 10.1097/mcg.0000000000001453
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Gastrointestinal Anastomosis Using Lumen-apposing Metal Stent (LAMS) for Benign or Malignant Etiologies

Abstract: FIGURE 8. Forest plot for clinical success for malignant etiologies. FIGURE 9. Forest plot for technical success for retrospective studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…In overall analysis, LAMS and BFMS were regarded the same kind, however in subgroup analysis, they were separated. Many studies have shown that the LAMS is safer and more effective for bile collection for biliary and gallbladder illnesses [ 43–46 ]. Single-arm studies also showed LAMS are safe and effective.…”
Section: Discussionmentioning
confidence: 99%
“…In overall analysis, LAMS and BFMS were regarded the same kind, however in subgroup analysis, they were separated. Many studies have shown that the LAMS is safer and more effective for bile collection for biliary and gallbladder illnesses [ 43–46 ]. Single-arm studies also showed LAMS are safe and effective.…”
Section: Discussionmentioning
confidence: 99%
“…Stent misdeplyoment was seen on 9.5% cases and re-interventions (any interventions during study period for stent malfunction or migration) were performed in 6% cases. [9 ▪ ]. The study included 203 patients (75.5%) with malignant cause and had a median follow up of 114 days.…”
Section: Discussionmentioning
confidence: 99%
“…The recent meta-analysis showed that EUS-GE had a 92%–94% technical success and a 90%–91% clinical success. [ 1 2 3 ] Stent misdeployment is not an unusual pitfall occurring in 9.5% of reported cases. [ 3 ] The mobility of the small bowel may result in loss of visualization and subsequent stent misdeployment.…”
mentioning
confidence: 99%
“…[ 1 2 3 ] Stent misdeployment is not an unusual pitfall occurring in 9.5% of reported cases. [ 3 ] The mobility of the small bowel may result in loss of visualization and subsequent stent misdeployment. [ 4 ] Insertion of the guidewire can push the small bowel away, thus increasing the risk of stent misdeployment.…”
mentioning
confidence: 99%